Cimetidine

Cimetidine was the first H2-receptor antagonist to achieve widespread clinical use, blocking histamine-stimulated gastric acid secretion for peptic ulcer disease and GERD, and historically notable for significant CYP450 drug interaction potential. Simson Pharma's Cimetidine reference standard and impurities support compendial testing for this historically significant antisecretory agent.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cimetidine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cimetidine
Cimetidine EP Impurity E
Cimetidine EP impurity H
Cimetidine EP Impurity J Dihydrochloride
Cimetidine EP Impurity A
Cimetidine Impurity 3
Cimetidine EP Impurity D Dihydrochloride
Cimetidine EP Impurity C Dihydrochloride
1,1-Dimethyl-3-cyanoguanidine
Cimetidine EP Impurity I
Cimetidine EP Impurity B
Cimetidine EP Impurity F
Cimetidine Impurity 1
Cimetidine Impurity 2
N-Nitroso Cimetidine
Cimetidine EP Impurity C
Cimetidine EP Impurity G
(5-Ethyl-1H-imidazol-4-yl)methanol hydrochloride
Cimetidine EP Impurity J Dihydrobromide
Cimetidine EP Impurity A Hydrochloride
Cimetidine EP Impurity J
Cimetidine Nitroso Impurity 4
Cimetidine EP Impurity B Hydrochloride Salt
Guanidine,N-cyano-N``-methyl-N`-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-,dihydrochloride
Cimetidine Impurity 3

Isotope Labelled Compounds

Cimetidine-D3